Noninfectious uveitis: strategies to optimize treatment compliance and adherence

Rosa Dolz-Marco,1 Roberto Gallego-Pinazo,1 Manuel Díaz-Llopis,2 Emmett T Cunningham Jr,3–6 J Fernando Arévalo7,8 1Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, 2Faculty of Medicine, University of Valencia, Spain; 3Department...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M, Cunningham Jr ET, Arévalo JF
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/1aff6e77609b4926a48c60b271fa6b27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1aff6e77609b4926a48c60b271fa6b27
record_format dspace
spelling oai:doaj.org-article:1aff6e77609b4926a48c60b271fa6b272021-12-02T09:08:36ZNoninfectious uveitis: strategies to optimize treatment compliance and adherence1177-5483https://doaj.org/article/1aff6e77609b4926a48c60b271fa6b272015-08-01T00:00:00Zhttp://www.dovepress.com/noninfectious-uveitis-strategies-to-optimize-treatment-compliance-and--peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Rosa Dolz-Marco,1 Roberto Gallego-Pinazo,1 Manuel Díaz-Llopis,2 Emmett T Cunningham Jr,3–6 J Fernando Arévalo7,8 1Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, 2Faculty of Medicine, University of Valencia, Spain; 3Department of Ophthalmology, California Pacific Medical Center, San Francisco, 4Department of Ophthalmology, Stanford University School of Medicine, Stanford, 5The Francis I Proctor Foundation, University of California San Francisco Medical Center, 6West Coast Retina Medical Group, San Francisco, CA, USA; 7Vitreoretina Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 8Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA Abstract: Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient’s ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence. Keywords: noninfectious uveitis, intraocular inflammation, immunosuppressive treatment, adherence, compliance, therapeutic failureDolz-Marco RGallego-Pinazo RDíaz-Llopis MCunningham Jr ETArévalo JFDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1477-1481 (2015)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Dolz-Marco R
Gallego-Pinazo R
Díaz-Llopis M
Cunningham Jr ET
Arévalo JF
Noninfectious uveitis: strategies to optimize treatment compliance and adherence
description Rosa Dolz-Marco,1 Roberto Gallego-Pinazo,1 Manuel Díaz-Llopis,2 Emmett T Cunningham Jr,3–6 J Fernando Arévalo7,8 1Unit of Macula, Department of Ophthalmology, University and Polytechnic Hospital La Fe, 2Faculty of Medicine, University of Valencia, Spain; 3Department of Ophthalmology, California Pacific Medical Center, San Francisco, 4Department of Ophthalmology, Stanford University School of Medicine, Stanford, 5The Francis I Proctor Foundation, University of California San Francisco Medical Center, 6West Coast Retina Medical Group, San Francisco, CA, USA; 7Vitreoretina Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 8Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA Abstract: Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient’s ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence. Keywords: noninfectious uveitis, intraocular inflammation, immunosuppressive treatment, adherence, compliance, therapeutic failure
format article
author Dolz-Marco R
Gallego-Pinazo R
Díaz-Llopis M
Cunningham Jr ET
Arévalo JF
author_facet Dolz-Marco R
Gallego-Pinazo R
Díaz-Llopis M
Cunningham Jr ET
Arévalo JF
author_sort Dolz-Marco R
title Noninfectious uveitis: strategies to optimize treatment compliance and adherence
title_short Noninfectious uveitis: strategies to optimize treatment compliance and adherence
title_full Noninfectious uveitis: strategies to optimize treatment compliance and adherence
title_fullStr Noninfectious uveitis: strategies to optimize treatment compliance and adherence
title_full_unstemmed Noninfectious uveitis: strategies to optimize treatment compliance and adherence
title_sort noninfectious uveitis: strategies to optimize treatment compliance and adherence
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/1aff6e77609b4926a48c60b271fa6b27
work_keys_str_mv AT dolzmarcor noninfectiousuveitisstrategiestooptimizetreatmentcomplianceandadherence
AT gallegopinazor noninfectiousuveitisstrategiestooptimizetreatmentcomplianceandadherence
AT diacuteazllopism noninfectiousuveitisstrategiestooptimizetreatmentcomplianceandadherence
AT cunninghamjret noninfectiousuveitisstrategiestooptimizetreatmentcomplianceandadherence
AT areacutevalojf noninfectiousuveitisstrategiestooptimizetreatmentcomplianceandadherence
_version_ 1718398228269891584